Dashboard
Curated content
Companies
Funding rounds
Exits
Investors
Accelerators
Matching tool
Investment heatmap
News
Companies
IGXBio
Team
Team
Save
IGXBio
Biotechnology company developing advanced dna immunotherapies for hiv infection.
Launch date
2001
Employees
2-10 people
Market cap
-
Enterprise valuation
€2—3m
(Dealroom.co estimates Dec 2010.)
Lenexa Kansas (HQ)
http://igxbio.com
B2B
health
biotechnology
hard tech
biotechnology
biotech and pharma
genetics
dna
genome engineering
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Authorizing premium user...